Sorensen, Eric P <br/><br/>
Tumor Necrosis Factor Inhibitor Primary Failure Predicts Decreased Ustekinumab Efficacy in Psoriasis Patients.  [electronic resource] 

 -  Journal of drugs in dermatology : JDD  Aug 2015 
 - 893-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1545-9616 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Dermatologic Agents--therapeutic use<br/>Etanercept--therapeutic use<br/>Female<br/>Humans<br/>Infliximab--therapeutic use<br/>Male<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Retreatment<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Treatment Failure<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Ustekinumab--therapeutic use